Clinical Trials Logo

Eczema clinical trials

View clinical trials related to Eczema.

Filter by:

NCT ID: NCT04472546 Completed - Healthy Clinical Trials

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

Start date: December 13, 2019
Phase: N/A
Study type: Interventional

The physiological states of the skin are characterized by a certain homeostasis linked to the balance of the metabolic pathways. When these pathways are deregulated, the proteic, lipidic and metabolic is affected. It is thus possible to follow a change in the state of the skin by looking at change in the associated molecular profile. The PRISM laboratory (INSERM U1192) in Lille has developed an innovative system laser called SpiderMass composed of 4 parts: 1. A laser used for the micro-sampling of material in vivo, 2. A transport transfer line of the ablated particles, 3. A mass spectrometer that analyzes them in real time and generates the molecular profiles of the epidermis, 4. A data analysis procedure. The SpiderMass(TM) is of great interest for the study of the skin because it allows non-invasive vivo characterization, and therefore without biopsy or sample preparation. In addition, it will complement techniques already used in the research center such as FTIR spectroscopy. Indeed, in acne studies the FTIR allows to obtain only the Fatty Acid Triglycerid ratio while the SpiderMass permits to detail these lipid classes by each observed molecule on the surface of the skin and follow their evolution.

NCT ID: NCT04471896 Completed - Acne Clinical Trials

Joovvin' for Your Skin Health Study

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

Sixty day single arm trial examining self-report and remote dermatology assessment of cosmetic skin health after daily 10-20 minute sessions with an infrared light therapy device (the Joovv Mini)

NCT ID: NCT04468711 Completed - Atopic Dermatitis Clinical Trials

Vitamin D in Egyptian Children With Atopic Dermatitis

Start date: June 6, 2018
Phase: Phase 3
Study type: Interventional

There is an emergent evidence demonstrating the role of Vitamin D deficiency in eczema. Vitamin D supplementation with standard treatment yielded positive clinical outcomes for children and adolescents with mild and moderate AD; however, the potential benefit of vitamin D in severe cases remains unclear

NCT ID: NCT04462055 Terminated - Food Allergy Clinical Trials

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

Start date: May 1, 2019
Phase:
Study type: Observational [Patient Registry]

This study evaluates the effectiveness of Dupilumab in food allergic patients with moderate to severe Atopic Dermatitis (AD). Included patients participated in the BioDay Registry.

NCT ID: NCT04449575 Recruiting - Hand Eczema Clinical Trials

Hand Eczema in the Health Care Sector

Start date: July 1, 2020
Phase:
Study type: Observational

This project aims to investigate the prevalence of bacterial colonization and associated factors in health care workers with hand eczema with focus on Staphylococcus aureus.

NCT ID: NCT04447417 Completed - Atopic Dermatitis Clinical Trials

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

BALISTAD
Start date: July 16, 2020
Phase: Phase 4
Study type: Interventional

Primary Objective: - Evaluate changes in skin barrier function with transepidermal water loss (TEWL) assessed after skin tape stripping (STS) in pre-defined lesional skin in participants with moderate to severe atopic dermatitis (AD) treated with dupilumab. Secondary Objectives: - Evaluate changes in skin barrier function with TEWL assessed after STS in pre-defined lesional and non-lesional skin in participants with moderate to severe AD treated with dupilumab in reference to normal skin of healthy volunteers. - Evaluate time course of skin barrier function with TEWL assessed before and after STS in pre-defined lesional and non-lesional skin in participants with moderate to severe AD treated with dupilumab in reference to normal skin of healthy volunteers.

NCT ID: NCT04445298 Recruiting - Pregnancy Related Clinical Trials

Skin Barrier Assessment in Pregnancy and at Birth

Start date: August 3, 2020
Phase:
Study type: Observational

This is a prospective birth cohort study assessing the role of maternal and environmental factors on the development of allergic diseases in children. Pregnant mothers will be enrolled and we will examine her skin barrier with skin tape strips (STS) and transepidermal water loss (TEWL), along with blood work. We will then follow her offspring and perform similar testing, along with detailed questionnaires inquiring about exposures such as use of detergents and soaps, sunlight exposure, and pollution exposure. When the infant is around 12 months old, we will contact the family via telephone to see if the child developed any allergic conditions within their first year of life, such as eczema, food allergy, or wheezing. A final questionnaire will be performed.

NCT ID: NCT04444752 Completed - Clinical trials for Moderate-to-severe Atopic Dermatitis

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Start date: July 17, 2020
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of CBP-201 in adult subjects with moderate to severe atopic dermatitis.

NCT ID: NCT04444726 Completed - Atopic Dermatitis Clinical Trials

Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children.

Start date: January 20, 2019
Phase: N/A
Study type: Interventional

this study is conducted to compare the effect of phototherapy" psoralen plus UVA " bath puva to tap water iontophoresis in the treatment of atopic dermatitis in children.

NCT ID: NCT04438330 Completed - Allergy Clinical Trials

The Immunological Profile of Nickel Dermatitis

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

A dose-response study on the immune phenotype of allergic nickel dermatitis on a previously exposed skin area.